Structures by: Tykarska E.
Total: 26
2,3-dicyano-5,6-bis-4-(benzyloxy)phenyl pyrazine
C32H22N4O2
New J. Chem. (2017) 41, 9 3586
a=8.2968(3)Å b=11.2161(5)Å c=27.6291(10)Å
α=90° β=97.453(3)° γ=90°
2,3-Dicyano-5,6-bis-4-[3,5-bis(benzyloxy)benzyloxy]phenyl pyrazine
C60H46N4O6,2(CH2Cl2)
New J. Chem. (2017) 41, 9 3586
a=23.8249(7)Å b=15.5643(4)Å c=16.2565(4)Å
α=90° β=117.473(3)° γ=90°
N-(2-pyridyl)N-benzylaminoethanol
C14H16N2O
New Journal of Chemistry (2012) 36, 3 603
a=10.756(2)Å b=5.9260(12)Å c=18.840(4)Å
α=90.00° β=99.58(3)° γ=90.00°
N-(2-pyridyl)amino-1-ethanol
C7H10N2O
New Journal of Chemistry (2012) 36, 3 603
a=8.8410(18)Å b=9.0530(18)Å c=8.6300(17)Å
α=90.00° β=90.00° γ=90.00°
N-(2-pyridyl)amino-1-phenyloethanol
C13H14N2O
New Journal of Chemistry (2012) 36, 3 603
a=6.0480(12)Å b=7.3150(15)Å c=24.334(5)Å
α=90.00° β=90.00° γ=90.00°
N-(2-pyrimidyl)amino-1-phenyloethanol
C12H13N3O
New Journal of Chemistry (2012) 36, 3 603
a=5.6050(11)Å b=20.972(4)Å c=9.5000(19)Å
α=90.00° β=108.11(3)° γ=90.00°
Bis{N-(2-pyridyl)aminoethyl}carbonate
C15H18N4O3
New Journal of Chemistry (2012) 36, 3 603
a=32.334(7)Å b=5.7910(12)Å c=16.392(3)Å
α=90.00° β=104.42(3)° γ=90.00°
Ethyl ester of glycyrrhetinic acid
C32H50O4
Acta Crystallographica Section B (2016) 72, 4 584-592
a=12.9577(5)Å b=13.0369(4)Å c=16.3908(5)Å
α=90° β=90° γ=90°
4-etylmorpholine ester of glycyrrhetinic acid
C36H57NO5
Acta Crystallographica Section B (2016) 72, 4 584-592
a=12.87000(10)Å b=13.6972(2)Å c=18.5682(3)Å
α=90° β=90° γ=90°
Isopropyl ester of glycyrrhetinic acid
C33H52O4
Acta Crystallographica Section B (2016) 72, 4 584-592
a=11.7789(2)Å b=13.0812(3)Å c=18.7845(4)Å
α=90° β=90° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid propionic acid solvate
c34H50O7,C3H6O2
Acta Crystallographica Section B (2015) 71, 1
a=13.0640(3)Å b=7.3190(2)Å c=18.6170(4)Å
α=90° β=103.515(2)° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid
C34H50O7
Acta Crystallographica Section B (2015) 71, 1
a=7.47600(10)Å b=35.9810(5)Å c=11.3590(2)Å
α=90° β=90.9440(10)° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid : monosodium (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxylatopropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid water/butan-2-one solvate
C34H50O7,C34H49NaO7,2.0(H2O),2.0(C4H8O)
Acta Crystallographica Section B (2015) 71, 1
a=7.34970(10)Å b=11.80610(10)Å c=42.4208(4)Å
α=90° β=92.4760(10)° γ=90°
2-(5-Bromo-2-methyl-4-nitroimidazol-1-yl)-1-(2-chlorophenyl)ethanone
C12H9BrClN3O3
Acta Crystallographica Section E (2007) 63, 4 o1669-o1671
a=8.4929(8)Å b=23.8609(13)Å c=7.5005(5)Å
α=90.00° β=120.190(7)° γ=90.00°
Rifampicin pentahydrate
C43H58N4O12,5(H2O)
Acta Crystallographica Section C (2012) 68, 5 o209-o212
a=13.8506(6)Å b=17.3867(8)Å c=19.7476(8)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium glicyrrhizinate 3.0 DMF 6.53 water solvate
C42H61O16,3.00(C3H7NO),6.53(H2O),H4N
Crystal Growth & Design (2014) 14, 11 5871
a=10.2250(3)Å b=11.4024(3)Å c=53.2811(14)Å
α=90° β=90° γ=90°
Monoammonium beta-glycyrrhizate complex with p-aminobenzoic acid 3.53 methanol 1.82 water solvate
C42H61O16,C7H7NO2,3.53(CH4O),H4N,1.82(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.4464(2)Å b=11.2468(2)Å c=51.0762(5)Å
α=90.00° β=90.00° γ=90.00°
Glycyrrhizic acid 4.26 propionic acid 3.94 water solvate
C42H62O16,4.26(C3H6O2),3.94(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.6054(2)Å b=11.3456(2)Å c=52.5014(5)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium beta-glycyrrhizate 3.53 methanol 1.82 water solvate
C42H61O16,6.25(CH4O),H4N,2.04(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.3718(2)Å b=11.2995(2)Å c=50.3536(6)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium glicyrrhizinate 4.0 propionic acid 3.0 water solvate
C42H61O16,4.00(C3H6O2),3.0(H2O),H4N
Crystal Growth & Design (2013) 13, 3 1301
a=10.6684(2)Å b=11.12450(10)Å c=51.3881(7)Å
α=90.00° β=90.00° γ=90.00°
Monopotassium glicyrrhizinate 5.66 acetic acid 2.02 water solvate
C42H61O16,K,5.64(C2H4O2),2.08(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.1563(3)Å b=11.1999(5)Å c=53.6150(15)Å
α=90.00° β=90.00° γ=90.00°
Monocaesium glicyrrhizinate 3.79 propionic acid 3.21 water solvate
C42H61O16,Cs,3.79(C3H6O2),3.21(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.6730(2)Å b=11.1804(2)Å c=51.5673(12)Å
α=90.00° β=90.00° γ=90.00°
Diammonium glicyrrhizinate 3.0 DMF 2.0 water solvate
C42H60O16,2.00(NH4),3.00(C3H7NO),2.0(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=9.8550(4)Å b=11.2823(3)Å c=52.659(3)Å
α=90.00° β=90.00° γ=90.00°
Dipotassium glicyrrhizinate 3.0 DMF 2.0 water solvate
C42H60O16,K2,3.00(C3H7NO),2.0(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=9.84050(10)Å b=11.25200(10)Å c=52.2345(2)Å
α=90.00° β=90.00° γ=90.00°
Dicaesium glicyrrhizinate 3.00 DMF 3.40 water solvate
C42H60O16,Cs2,3.00(C3H7NO),3.40(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.28540(10)Å b=11.48450(10)Å c=51.8388(6)Å
α=90.00° β=90.00° γ=90.00°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid dimethoxyethan solvate
C34H50O7,C4H10O2
Acta Crystallographica Section B (2015) 71, 1
a=7.2834(2)Å b=11.6425(3)Å c=41.9069(15)Å
α=90° β=90° γ=90°